Start an analysis for AZR
Azora Therapeutics, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $4 | 30-Jun-26 | 10-Q filed 14-Aug-26 |
| Remaining authorization | $4EST | 30-Jun-26 | 10-Q filed 14-Aug-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 12-Aug-26 | $4 | $4EST | n/a | Purchase Agreement Amendment decreased the Minimum Issuance Price from $4.25 to $4.0010-Q filed 14-Aug-26 |
Open-market repurchases
None reported in the filings we hold.